Neuromuscular Monitoring
11
1
1
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
9.1%
1 terminated out of 11 trials
87.5%
+1.0% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
Development and Validation of an Android-based Application for Anaesthesia Neuromuscular Monitoring
Evaluation of Neuromuscular Blockade Responses in Statin-Using and Non-Using Patients
Management of Neuromuscular Blocking Agents and Their Antagonism
A Comparison Between TOF Watch® SX and Tetragraph®
Electromyography and Acceleromyography in Ventilated ICU Patients
Infantile - Postoperative Residual Curarization - Study
Intraoperative Methylprednisolone and Sugammadex
Neurostimulation and Electromyographs Assessment of th TetraGraph in Healthy (Volunteers
Comparison of Two Neuromuscular Transmission Monitors Based on Acceleromyography: TOF-Watch SX® and TOFScan®
Rocuronium Consumption in Etomidate-based and Propofol-based General Anesthesia Under Sevoflurane
Comparison of Two Neuromuscular Monitors